1.Decreased Serum Sulphydryl Levels as a Sign of Increased Oxidative Stress in Generalized Anxiety Disorder.
Mehmet Cemal KAYA ; Yasin BEZ ; Ibrahim Fatih KARABABA ; Ali EMHAN ; Nurten AKSOY ; Mahmut BULUT ; Mehmet GUNES ; Abdullah ATLI ; Salih SELEK
Psychiatry Investigation 2013;10(3):281-285
OBJECTIVE: In recent years, many published studies have focused on the relationship between oxidative stress and psychiatric disorders. However, studies in generalized anxiety disorder (GAD) are few despite relatively high prevalence rates. In an attempt to fill this gap in the literature we aimed to measure serum levels of free sulphydryl, an important member of antioxidant defense mechanisms, of the patients with GAD. METHODS: A total of 35 (23 female, 12 male) GAD patients without any other co-morbid medical or psychiatric disorder and 35 (23 female, 12 male) healthy controls have been included in the study. Disease severity of the patients were quantified by using the Hamilton Anxiety Rating Scale (HAM-A). Serum free sulphydryl group levels of patients and healthy controls were measured in an appropriate way. RESULTS: Mean level of serum sulphydryl groups was significantly lower in the patient group. There was a negative correlation between their level and the disease duration. However, they did not show any significant correlation with the disease severity. CONCLUSION: Decreased serum sulphydryl level observed in pure GAD patients suggests an increased oxidative stress in these patients. Well designed future researches are needed to replicate our findings and to test the implications of the present study.
Anxiety Disorders*
;
Anxiety
;
Defense Mechanisms
;
Female
;
Humans
;
Male
;
Oxidative Stress*
2.Cystic fibrosis of pancreas and nephrotic syndrome: a rare association.
Selvi KELEKCI ; Musemma KARABEL ; Aydin ECE ; Velat SEN ; Ali GUNES ; Ilyas YOLBAS ; Cahit SAHIN
Korean Journal of Pediatrics 2013;56(10):456-458
Cystic fibrosis (CF) is a genetic disease with autosomal recessive inheritance and is common in Caucasian people. The prevalence of this disease is between 1/2,000 and 1/3,500 live births, and the incidence varies between populations. Although the CF transmembrane conductance regulator gene is expressed in the kidneys, renal involvement is rare. With advances in the treatment of CF, life expectancy has increased, and some previously unobserved disease associations are now seen in patients with CF. It is important to follow patients with CF for possible abnormalities that may accompany CF. In this paper, we present two rare cases of CF accompanied by nephrotic syndrome.
Child
;
Cystic Fibrosis*
;
Genes, Regulator
;
Humans
;
Heredity
;
Incidence
;
Kidney
;
Life Expectancy
;
Nephrotic Syndrome*
;
Pancreas*
;
Prevalence